Skip to main content
All lobbying filings

WAXMAN STRATEGIES

WAXMAN STRATEGIES filed a Q3 report for 340B HEALTH on October 21, 2026, reporting $39,000 in lobbying income.

Lobbying for 340B HEALTH · advocacy and membership organization

All filings by WAXMAN STRATEGIES · Everything 340B HEALTH has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 21, 2026
Income
$39,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • HENRY WAXMAN Former member of Congress
    Previously held: US House of Representatives 1975 to 2015
  • JEREMY SHARP New on this filing
    Previously held: LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues affecting the 340B drug pricing program; appropriations for 340B program

Issues affecting the 340B drug pricing program; Appropriations for 340B program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem